dsRNA Removal Methods

• 

  Streamlining dsRNA removal for high-throughput sequencing applications

  What with technology as it is, the scientists often used to study kind of multiple RNA samples all at once. It is also known as high-throughput sequencing. As Yaohai knows that scientists have many samples to work with, they need a faster and efficient method to remove dsRNA. The technique allows us to physically remove the special dsRNA molecules and do this more quickly than genome sequencing. In plain English, this means that scientists can use the results earlier and concentrate more of their time on their actual research.

• 

  Choosing the right dsRNA removal technique for your research needs

  For the need of different research projects, there might be some other ways to eliminate dsRNA. Therefore in Yaohai we provides a lot of choices for the researchers, e.g. special treatments on enzymes or magnetic beads to pull out dsRNA. We are ready to help you choose the optimal method for your project with our team of experts. They also go to work listening to your problems and will steer you rather in the right direction, for getting maximal benefits. An appropriate approach allows scientists to have more faith in their results.

• 

  Overcoming challenges in dsRNA removal to confidently interpret your results

  While Isolation of dsRNA can easier said than done, and sometimes it could be tedious. Because RNA analysis can lead to significant discoveries, scientists must be confident in their results. During the dsRNA removal process, barriers may emerge, but Yaohai has formulated frameworks for defeating these challenges. This ensures that scientists have reliable results in the use of our cutting-edge techniques. This results in novel discoveries that can shift the way we view both health and disease from a genetic standpoint.

Why choose Yaohai dsRNA Removal Methods?

• System jakości i globalna zgodność z przepisami

  Yaohai BioPharma, a top 10 Microbial CDMO, integrates quality and regulatory matters. We have a quality system that is fully compliant with the current GMP standards, as well as international regulations. Our team of regulatory experts has a deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We are able to guarantee traceable production procedures and high-quality products that conform with regulations from the US FDA, dsRNA Removal Methods, Australia TGA, and China NMPA. Yaohai BioPharma has successfully passed an on-site audit conducted of the European Union's Qualified Person (QP) for our GMP quality system and production site. We also have been through the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Solidny łańcuch dostaw i możliwości produkcyjne

  Yaohai Bio-Pharma is a Top 10 biological company that specializes in dsRNA Removal Methods. We have built a modern manufacturing facility with robust RD capabilities and modern manufacturing facilities. Five drug substance production lines complying with GMP standards for microbial fermentation and purification along with two fill and final lines for vials and cartridges as well as pre-filled needles are readily available. The available fermentation scales vary between 100L and 2000L. The filling volume ranges from 1ml up to 25ml. Syringes or cartridges that are pre-filled are filled with 3 to 3.5ml. Our production workshop that is cGMP-compliant ensures constant supply of clinical sample and commercial products. Our facility produces large molecules that are exported to all over the world.

• Dostosowanie, wydajność i opłacalność

  Yaohai Bio-Pharma has experience in the manufacture of biologics derived from microorganisms. We offer tailored RD solutions and manufacturing while minimizing the risk. We have worked with diverse methods, such as dsRNA Removal Methods of vaccines (including peptides), growth factors, hormones, and Cytokines. We specialized in multiple microbial hosts, including yeast extracellular and intracellular (yield up to 15 g/L) bacteria periplasmic secretion, soluble intracellular, and inclusion bodies (yield up to 10 grams/L). We also have a BSL-2 fermentation platform to create bacterial vaccines. We specialize in improving processes, increasing product yields, as well as reducing production costs. We have an efficient technology team that guarantees timely and quality project delivery. This allows us to deliver your exclusive products quicker to market.

• Profesjonalna wiedza i bogate doświadczenie

  Yaohai Bio-Pharma, a leader in CDMOs of microbial biologics, is headquartered in Jiangsu. We have been focused on microbially produced therapeutics and vaccines that are suited for human, veterinary and the management of dsRNA Removal Methods. We have the most the most advanced RD as well as manufacturing technology platforms, which cover the entire process from Microbial strain engineering, cell banking as well as process and method development to commercial and clinical manufacturing, assuring the successful supply of the most cutting-edge solutions. We have accumulated a huge amount of experience in the bio processing of microbial cells. We have delivered over 200 projects across the globe and have assisted our clients with navigating the rules and regulations of the US FDA, EU EMA, Australia TGA, and China NMPA. Our expert knowledge and vast experience enable us to swiftly adapt to market needs and offer tailored CDMO services.

Powiązane kategorie produktów

• Produkcja bakteriofaga AP205 VLP
• Produkcja bakteriofaga Q VLP
• Produkcja szczepionki chimerycznej VLP
• Produkcja koniugowanych szczepionek VLP
• Produkcja szczepionek DNA
• Fermentacja E. coli do produkcji VLP
• Produkcja agonisty GLP-1
• Produkcja analogowa GLP-1
• Produkcja fragmentów GLP-1
• Produkcja mutacji GLP-1

Nie możesz znaleźć tego, czego szukasz?
Skontaktuj się z naszymi konsultantami, aby uzyskać więcej dostępnych produktów.